← Back to catalogue
COOLPRENE X Ankle Sleeve with Open Heel
EUDAMEDClass I (EU MDR)
Ref FT15CA-BK-LRef 704CAR1-BK-LRef 704CAR1-BK-MRef FT15CA-BK-S
Identity
- Trade Name
- COOLPRENE X Ankle Sleeve with Open Heel EUDAMED
- Device Name
- LOWER EXTREMITY ORTHOSES EUDAMED
- Model / Reference
- FT15CA-BK-L EUDAMED704CAR1-BK-L EUDAMED704CAR1-BK-M EUDAMEDFT15CA-BK-S EUDAMED
Identifiers
- Primary DI / UDI-DI
- 00840269507519 EUDAMED00840269505447 EUDAMED00840269505430 EUDAMED00840269507502 EUDAMED
- Basic UDI-DI
- 08402695CL1028E EUDAMED
- EMDN Code
- Y061299 LOWER EXTREMITY ORTHOSES - OTHER EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Netherlands EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
COOLPRENE X Ankle Sleeve with Open Heel by La Pointique Int´l Ltd. — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 08402695CL1028E | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- La Pointique Int´l Ltd.
- EUDAMED SRN
- US-MF-000005204
- Authorised Representative
- Medical Technology Promedt Consulting GmbH DE-AR-000000085
Sources (4)
- EUDAMED 8c331d05-e310-43c5-a3fa-5a3aa89fe008 61 fields · synced Jul 31, 2026
- EUDAMED 7e382814-53a0-4e6f-89e9-c54907604acb 61 fields · synced May 18, 2026
- EUDAMED 9f23228d-98de-4d01-adf7-580bc4989686 61 fields · synced May 18, 2026
- EUDAMED b44ea619-85a2-47ae-a9e4-dfbcc84d9ddf 61 fields · synced May 18, 2026